Diyabit kisilige yingi dora

Diyabit kisilige yingi dora

2-Tipliq diyabit kisilige ishlitilidighan BYDUREON dep atalghan yingi dora FDA teripidin testiqlanghan bolup, bu dorining harir bar bolghan dorilar bilen bolghan eng chong periqi bir heptide birla qitim ishletse qandiki shiker maddisi yahshi konturul bolidiken. Hazir bar bolghan diyabit kisilining dorilirini bolsa kunige bir we bir nechche qitim ishletkende, andin qandiki shiker yahshi konturul bolatti. Bu dorining bazargha kirishi 2-tipliq diyabit kisilige giriptar bolghan bimarlargha kop qolayliq ilip kelgusi.

Bydureon, a Diabetes Drug from Amylin, Wins F.D.A. Approval

www.nytimes.com

The Food and Drug Administration twice declined to approve Bydureon in 2010, with its most serious concern being that the drug might contribute to heart rhythm abnormalities.